CORD-19:e847d433e7424152a9846673209cb73027415ecd / 76592-76841 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T775","span":{"begin":0,"end":249},"obj":"Sentence"},{"id":"T34129","span":{"begin":0,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the univariate analysis, factors significantly associated with REC-BSI were: male sex (OR 3.15;1.64-6.06), immunosupression (OR 4.48; ), haematological malignancy (OR 11.63;1.41-90.91), non-urinary origin (OR 5.36; and McCabe I and II (OR 2.35; ."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T90","span":{"begin":0,"end":249},"obj":"Epistemic_statement"}],"text":"In the univariate analysis, factors significantly associated with REC-BSI were: male sex (OR 3.15;1.64-6.06), immunosupression (OR 4.48; ), haematological malignancy (OR 11.63;1.41-90.91), non-urinary origin (OR 5.36; and McCabe I and II (OR 2.35; ."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T328","span":{"begin":0,"end":249},"obj":"Sentence"}],"text":"In the univariate analysis, factors significantly associated with REC-BSI were: male sex (OR 3.15;1.64-6.06), immunosupression (OR 4.48; ), haematological malignancy (OR 11.63;1.41-90.91), non-urinary origin (OR 5.36; and McCabe I and II (OR 2.35; ."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T294","span":{"begin":70,"end":73},"obj":"Disease"},{"id":"T38412","span":{"begin":70,"end":73},"obj":"Disease"}],"attributes":[{"id":"A294","pred":"mondo_id","subj":"T294","obj":"http://purl.obolibrary.org/obo/MONDO_0015085"},{"id":"A75443","pred":"mondo_id","subj":"T38412","obj":"http://purl.obolibrary.org/obo/MONDO_0015085"}],"text":"In the univariate analysis, factors significantly associated with REC-BSI were: male sex (OR 3.15;1.64-6.06), immunosupression (OR 4.48; ), haematological malignancy (OR 11.63;1.41-90.91), non-urinary origin (OR 5.36; and McCabe I and II (OR 2.35; ."}